Health ❯Medicine

Pharmacology

Drug Development Antibiotics Weight Loss Drugs Weight Loss Antivenom Pain Management Diabetes Antidepressants Opioids Diabetes Treatment

Amgen Advances Monthly Obesity Drug to Phase 3 After 20% Weight Loss in Mid-Stage Trial

Amgen plans to use lower starting doses with gradual escalation to improve tolerability ahead of expanded Phase 3 studies

Researchers Transform Ancient Tomb Fungus Into Potent Antileukemia Compound

Semaglutide Demonstrates Dual Promise in Type 1 Diabetes and Dementia Prevention

Experimental Drug SANA Boosts Fat Thermogenesis to Promote Weight Loss Ahead of Phase 2 Trials

Novo Nordisk’s Amycretin Achieves Up to 24% Weight Loss as It Advances to Phase 3

New Oral β2 Agonist Preserves Muscle in Early Weight-Loss Trials

Liraglutide Cuts Chronic Migraine Days by More Than Half

PDE3 Inhibitors Stimulate Bone Growth in Mice, Offering Potential for Skeletal Disorder Therapies

Cancer Cell Cholesterol Depletion Heightens Hyperthermia Treatment Efficacy

Long-Term Desogestrel Use Linked to Slight Rise in Brain Tumor Risk

Real-World GLP-1 Therapy Yields Lower Weight Loss, Spurs Tetra-Receptor Drug Research

Green-Light-Activated Penicillin Enables Precise Control of Bacterial Infections

Acetaminophen Metabolite AM404 Targets Peripheral Nerves to Relieve Pain

Researchers Seek Synthetic Route for Sea Cucumber Compound That Blocks Cancer Enzyme

Antibiotic Energy Drain Found to Accelerate Bacterial Resistance

Ozempic and Wegovy Users Face Dental Decay and Unusual Scent Cravings

Two Distant Plants Independently Evolved Medicinal Ipecac Alkaloids

Cancer drug pair extends mouse lifespan by 30% as researchers plan human trials

Disulfiram Inhibits Pyroptosis to Reduce Trauma Damage, Showing Greater Benefit in Females

GLP-1 Drugs Associated with Reduced Obesity-Related Cancer and Mortality Risks